Naproxen or low-dose colchicine for gout flares in primary care? Response to: 'Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care' by Parperis et al.

Roddy, Edward; Mallen, Christian

Abstract

Correspondence response.

Citation

Roddy, E., & Mallen, C. (2019). Naproxen or low-dose colchicine for gout flares in primary care? Response to: 'Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care' by Parperis et al. Annals of the Rheumatic Diseases, https://doi.org/10.1136/annrheumdis-2019-216671

• Acceptance Date: Nov 26, 2019
• Publication Date: Dec 4, 2019
• Journal: Annals of the Rheumatic Diseases
• Print ISSN: 0003-4967
• Publisher: BMJ Publishing Group
• DOI: https://doi.org/10.1136/annrheumdis-2019-216671
• Keywords: NSAIDs, gout, treatment
• Public URL: https://keele-repository.worktribe.com/output/415279
• Publisher URL: http://doi.org/10.1136/annrheumdis-2019-216671